Hyperphosphorylated Tau has been demonstrated to be associated with synaptic loss, cytoskeletal damage, and dysfunction in axonal transport in AD (Haditsch et al., 2020; Jiang et al., 2021; Tang et al., 2021). The gene discussed is MAPT; the disease is Alzheimer disease.